What's new? Log in Free sign up

Filing search / Prime Medicine, Inc. / "Corruption"

Search information

Prime Medicine, Inc.

Companies

"Corruption"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

20 results

Newest first Best match first

PRME Prime Medicine, Inc.

, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry

28 Feb 25

8:13am

PRME Prime Medicine, Inc.

Quarterly report

Schedules 50 9.6 Anti-Bribery and Anti-Corruption Compliance 50 9.7 Additional Covenants 50 9.8 Warranty Disclaimer 51 ARTICLE 10. INDEMNIFICATION 51 10.1 … the Effective Date. 1.16“Anti-Corruption Laws” has the meaning set forth in Section 9.6.1. 1.17“Applicable Law” means any federal, state, local, national

12 Nov 24

4:10pm

PRME Prime Medicine, Inc.

Quarterly report

or anti-corruption law; (iv) has made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit … , or anything else of value, to any person in violation of any applicable anti-corruption laws. The Company and its Subsidiaries have conducted

12 Nov 24

4:10pm

PRME Prime Medicine, Inc.

and the U.K. Bribery Act is expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents

1 Mar 24

8:04am

PRME Prime Medicine, Inc.

Entry into a Material Definitive Agreement

applicable anti-bribery or anti-corruption law; (iv) has made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe … of the payment or giving of money, or anything else of value, to any person in violation of any applicable anti-corruption laws. The Company and its

pifmxfcglwnte4y bre0

Shelf registration

Quarterly report

11 May 23

8:22am

Quarterly report

Prospectus supplement with pricing info

l2fa453w9f6qo2o

IPO registration (amended)

17 Oct 22

2:31pm

svbakna48riiyjm3c

IPO registration (amended)

ddi7xmq09 j96f29b6

IPO registration

vj7cf8ho1 9i509

IPO registration

ov48xcwf gtih6eh98

Draft registration statement (amended)

feefxksksweobo1kljp0

Draft registration statement (amended)

Draft registration statement (amended)

Draft registration statement (amended)

Draft registration statement (amended)

Draft registration statement (amended)

Draft registration statement

Prev
1
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.